This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Adverse Reactions Remove Documentation Remove Labelling Related Topics
Packaging Pharmaceutical Companies Immunization Vaccines FDA Medical Schools Pharmaceutical Companies Hospitals More Related Topics >
article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

SEPTEMBER 2, 2022

This can be achieved by reducing the burden of adverse reactions or by optimising benefits through patient selection (eg, contraindications, recommendations of use, warnings, concomitant medicine[s], or certain test parameters) and treatment management (eg, specific dosing regimen, relevant testing, patient follow-up).

Adverse Reactions 78
Adverse Reactions Documentation Medical Schools Packaging 78
article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

MARCH 2, 2021

Adverse reactions to the vaccine. The data must be quickly documented and reported to public health agencies to ensure effective record keeping, equal access to the vaccine and patient safety. In a rollout of this magnitude, point of care facilities need to collect comprehensive vaccination data on: Individual patient records.

Vaccines 117
Vaccines Adverse Reactions Documentation Labelling 117
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024